News

Teva launches generic Baraclude tabs

BY Ryan Chavis

JERUSALEM — Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug. 
 
Baraclude (entecavir) tablets are marketed by Bristol-Myers Squibb and had annual sales of $328 million in the United States as of June 2014, according to IMS data. The drug is indicated as a treatment for chronic hepatitis B virus infection.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Target announces availability of flu vaccines at pharmacy, clinic locations

BY Antoinette Alexander

MINNEAPOLIS — Target announced on Thursday that flu vaccines are now available at all Target Pharmacy and Target Clinic locations nationwide.

Target will offer guests quadrivalent, trivalent and high dose. In addition, FluMist will be available later this month. All vaccines are also available in preservative-free options, the company noted.

“At Target, we know that prevention is key when it comes to keeping families healthy during the cold and flu season,” stated Kevin Ronneberg, medical director, Target. “We’re pleased to provide a variety of vaccine products to meet the needs of all our guests, including traditional shots as well as the nasal spray."

At Target, trained pharmacists and/or nurse practitioners administer flu vaccines, with no appointment necessary. Target pharmacies and clinics accept most insurance plans. In addition, flu vaccines are included in the Pharmacy Rewards program. Guests who enroll in Pharmacy Rewards and fill five eligible prescriptions at Target Pharmacy earn 5% off a day of Target shopping. Pharmacy Rewards savings can be added to the everyday 5% discount for REDcard holders, the company stated.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Rite Aid rings in $12.9 billion over 26-week fiscal period, up 3.2%

BY Michael Johnsen

CAMP HILL, Pa. — Rite Aid on Thursday reported a 3.2% lift in sales for the 26 weeks ended Aug. 30, ringing in $12.9 billion. 
 
Same-store sales for the period increased 3.6% over the prior-year period. Front-end same store sales increased 0.6%, while pharmacy same store sales increased 5.1%. Prescription count at comparable stores increased 3% over the prior-year period.
 
Prescription sales represented 68.6% of total drug store sales for the 26-week period, and third-party prescription sales represented 97.5% of pharmacy sales.
 
Same-store sales for the 13-week period ended Aug. 30 increased 4.1% over the prior-year period. Front-end same store sales increased 1.1% while pharmacy same store sales increased 5.6%. Prescription count at comparable stores increased 3.7% over the prior-year period.
 
Total drug store sales for the 13-week period increased 3.7% with sales of $6.5 billion. Prescription sales represented 68.8% of total drug store sales.
 
Rite Aid posted sales of $2.5 billion for the five weeks ended Aug. 30, representing a 3.7% lift. Same-store sales increased 3.9% over the prior-year period. August front-end same-store sales increased 1.1%. Pharmacy comparable sales, which included an approximate 219 basis points negative impact from new generic introductions, increased 5.2%. Prescription count at comparable stores increased 3.7% over the prior-year period.
 
Prescription sales accounted for 69.3% of drug store sales.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?